27th Annual Controversies in Cardiac Arrhythmias 2017

27th Annual Controversies in Cardiac Arrhythmias 2017 Banner

Date & Location
Friday, October 20, 2017, 7:00 AM - 4:45 PM, Cosmos Club, Washington, DC

Target Audience
Cardiac Electrophysiology, Cardiology, Family Medicine, Internal Medicine


Registration is now closed.

If you have a question about your registration, please contact Ashley Roseboro at (202) 780-1656 before 2:00 pm on Thursday, October 19, 2017. After 12 pm on Thursday, October 19, 2017 you will need to register on-site. 

On-site registration will open at the Cosmos Club, Washington DC at 7:15 am on Friday, October 20, 2017.

According to the American Heart Association, cardiac arrhythmias have an estimated prevalence of 14.4 million patients in the United States, and they account for more than 40,000 deaths annually. New developments and advances in the management of cardiac arrhythmias, such as newer anticoagulants, atrial appendage closure devices and CIEDs afford benefits to patients who suffer from these conditions. Novel analytical approaches and important clinical trials challenge the practicing physician to implement translation of those discoveries into his clinical practice. The gaps that form between new knowledge and changing paradigms in the practice of medicine can only be filled with effective dissemination of the emerging information.

This one-day program is designed to provide clinicians with a review of selected topics in present day management of patients with cardiac arrhythmias, emphasizing new advances in the field and incorporating current guidelines and evidence-based principles of practice. The format will incorporate didactic lectures as well as case management studies and panel discussions with experts in the field.

Target Audience

This conference is intended for cardiologists, internists, primary care physicians and other health care professionals with a special interest in the evaluation, diagnosis and management of patients with cardiac arrhythmias.

This meeting is endorsed by:



After completing this activity, the participant will be able to;
  1. Evaluate the pre-market and newly approved cardiac implantable electronic devices (CIEDs) available and select the most appropriate therapy for managing patients with cardiac arrhythmias.
  2. Assess evidence-based clinical studies defining the role of cardiac resynchronization therapy (CRT) for patients with persistent congestive heart failure (CHF).
  3. Compare and contrast the risks and benefits of warfarin vs. newer anticoagulants including the role of antidotes, and apply appropriate patient selection criteria for the treatment of patients with atrial fibrillation.
  4. Compare and contrast the risks and benefits of oral anticoagulation therapy vs. left atrial appendage (LAA) occlusion for the treatment of atrial fibrillation.
  5. Apply appropriate patient selection criteria for use of wearable defibrillator.
  6. Evaluate the leadless pacemaker and identify its role in arrhythmia management.


Registration for Controversies in Cardiac Arrhythmias 2017: $55

Cancellation Policy

Cancellations made in writing by September 8, 2017 will be subject to a 50% penalty. No refunds will be given after September 8, 2017. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, MedStar Health will refund the registration fee, but is not responsible for any travel costs.

Please call 202-780-1655 or email medstarcme@gmail.com if you have any questions or need any additional information.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedStar Georgetown University Hospital and MedStar Heart & Vascular Institute. The MedStar Georgetown University Hospital is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

MedStar Georgetown University Hospital designates this live activity for a maximum of 7.0 approved credits AMA PRA Category 1 Credits TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.